astrazeneca nasdaq - Search News

AstraZeneca, Calquence

AstraZeneca's Calquence gains FDA nod for 1L MCL treatment

AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN), a pharmaceutical giant with a market capitalization of $207.67 billion and impressive gross profit margins of 82.61%, announced that its drug Calquence (acalabrutinib),

Hosted on MSN · 1d

AstraZeneca lymphoma therapy Calquence gets expanded approval in the U.S.

AstraZeneca (NASDAQ:AZN) announced Friday that the U.S. FDA approved its Bruton’s tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) with chemoimmunotherapy as a first-line option for adults with mantle cell lymphoma,

Business Insider · 2d

AstraZeneca’s Calquence combination approved in U.S.

Calquence in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients

Investing.com on MSN · 1d

FDA approves new MCL treatment by AstraZeneca

WILMINGTON, Del. - The U.S. Food and Drug Administration (FDA) has granted approval to AstraZeneca (NASDAQ:AZN)'s CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation.

1don MSN

Guggenheim lifts AstraZeneca stock target, buy rating on prospects

Guggenheim adjusted its price target on shares of AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN), increasing it to GBP13,100 from ...

1don MSN

AstraZeneca said to have changed management of its China unit

AstraZeneca (AZN) changes key management roles in China as the company emerges from several scandals involving its executives ...

AZN INVESTOR ALERT: AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

If you suffered substantial losses and wish to serve as lead plaintiff of the AstraZeneca class action lawsuit, please provide your information here: You can also contact attorneys J.C. Sanchez or ...

AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Moody National Bank Trust Division

Moody National Bank Trust Division boosted its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 20.0% during ...

Nasdaq5d

Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. AstraZeneca plc, headquartered in London, UK, is one of the largest biopharmaceutical companies in the world.

4don MSN

Is AstraZeneca (AZN) Top Stock Pick in Billionaire George Soros’ Portfolio?

We recently published a list of Billionaire George Soros Stock Portfolio: Top 10 Stock Picks. In this article, we are going ...

13d

AstraZeneca: Uncertainty Ahead, Neutral Rating Confirmed.

Analysis of AstraZeneca's market potential, including China and IRA impacts, and the importance of key readouts in 2025 for ...

Nasdaq10d

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know

In the latest trading session, Astrazeneca (AZN ... Elsewhere, the Dow saw an upswing of 0.25%, while the tech-heavy Nasdaq depreciated by 0.06%. The the stock of pharmaceutical has fallen ...

12don MSN

Why Is AstraZeneca PLC (NASDAQ:AZN) Among the Best FTSE Dividend Stocks to Buy Now?

We recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we are going to take a look at ...

AstraZeneca (AZN) Faces Securities Class Action After Reports of PRC Probe into Fraud and Corruption - Hagens Berman

Hagens Berman has opened an investigation into the allegations and urges investors in AstraZeneca American Depositary Shares ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results